AURSOS, INC.

AURSOS, INC. is a biotechnology company developing drugs for the treatment of bone loss. It has developed black bear PTH (BB-PTH) 1-34 for the prevention and treatment of osteoporosis, as well as for patients suffering from osteoporosis due to chronic immobilization. The company was founded in 2007, with its headquarters located in Kalamazoo, Michigan, and an office in Houghton, Michigan.